Moreover, in some tumors, BHLHE40 appears to have a bimodal function – it is upregulated during tumor initiation, whereas its expression is lost during tumor progression, exhibiting a significant decrease in expression from well-differentiated to poorly differentiated tumors. Here, BHLHE40 is linked to neoplasm.